arginine vasopressin has been researched along with irl 1620 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, RM; Nambi, P; Pullen, M; Stack, EJ | 1 |
Hill, CE; Kirton, A; Vanner, SJ; Wu, DD | 1 |
Chen, H; Rossi, NF | 1 |
Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Nakayama, N | 1 |
4 other study(ies) available for arginine vasopressin and irl 1620
Article | Year |
---|---|
Endothelin inhibits vasopressin action in rat inner medullary collecting duct via the ETB receptor.
Topics: Animals; Arginine Vasopressin; Cell Membrane Permeability; Cells, Cultured; Cyclic AMP; Endothelin Receptor Antagonists; Endothelins; In Vitro Techniques; Iodine Radioisotopes; Kidney Medulla; Kidney Tubules, Collecting; Kinetics; Male; Osmotic Pressure; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Water | 1993 |
Role of maxi-K+ channels in endothelin-induced vasoconstriction of mesenteric and submucosal arterioles.
Topics: Animals; Arginine Vasopressin; Arterioles; Dinoprost; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelins; Guinea Pigs; Ileum; Intestinal Mucosa; Kinetics; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth; Muscle, Smooth, Vascular; Norepinephrine; Peptide Fragments; Peptides; Peptides, Cyclic; Potassium Channels; Potassium Channels, Calcium-Activated; Receptor, Endothelin A; Scorpion Venoms; Tetraethylammonium; Time Factors; Vasoconstriction | 1997 |
Modulation of ET(B) receptor-induced arginine-vasopressin secretion by N-methyl-D-aspartate (NMDA) and gamma-aminobutyric acid (GABA)-dependent mechanisms in hypothalamo-neurohypophysial explants.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Arginine Vasopressin; Dizocilpine Maleate; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Excitatory Amino Acid Antagonists; GABA Agonists; Hypothalamus; Male; Muscimol; Organ Culture Techniques; Peptide Fragments; Peptides, Cyclic; Phenoxybenzamine; Pituitary Gland, Posterior; Quinoxalines; Rats; Rats, Long-Evans; Receptor, Endothelin B; Receptors, Endothelin; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Secretory Rate | 2002 |
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Butadienes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Male; MAP Kinase Kinase Kinases; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitriles; Nitroarginine; Nitroprusside; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Vasoconstriction; Vasodilation | 2009 |